Projects / Řešené projekty
-
Projects / Řešené projekty 2019-2024
- 2024–2027, AZV No. NW24-03-00024: Predictive and prognostic factors for an individualized strategy of pancreatic cancer diagnosis and therapy;
- 2022–2025, AZV No. NU22-08-00186: Integromics concept in prediction of ovarian cancer therapy outcome and new therapeutic target identification;
- 2021–2024, GAČR No. 21-27902S: Telomere homeostasis from colorectal adenoma to metastatic cancer;
- 2019–2022, INTER-COST No. LTC19015: Whole exome profiling for discovery of pharmacogenomic biomarkers in patients with colorectal cancer;
- 2019–2021, GAČR No. 19-03063S: Role of novel suspect molecules associated with resistance of cancer cells to taxanes;
- 2019–2022, AZV No. NV19-08-00113: Feasibility study of next generation sequencing for individualized therapy of patients with solid tumors;
- 2018–2023, Charles University, project No. UNCE/MED/006: Center of clinical and experimental liver surgery;
- 2018–2022, Ministry of Education, Youth and Sports of the Czech Republic, project No. CZ.02.1.01/0.0/0.0/16_019/0000787 “Fighting infectious diseases” (FIND);
- 2018–2022, Ministry of Education, Youth and Sports of the Czech Republic, project No. CZ.02.1.01/0.0/0.0/16_019/0000860 “International competitiveness of NIPH in research, development and education in alternative toxicological methods” (REDEALTOX);
- 2017–2020, AZV No. 17-28470A: Importance of oxysterol signaling for endocrine therapy of breast carcinoma;
- 2017–2020, AZV No. 17-28231A: Expression of biotransformation enzymes in hepatocellular carcinoma;
- 2016–2019, AZV No. 16-28375A: Study of prognostic and predictive biomarkers in therapy of pancreatic carcinoma;
Collaborations / Aktivní zahraniční spolupráce
- Prof. F. Peter Guengerich, Ph.D. – Center in Molecular Toxicology, Medical School, Vanderbilt University, Nashville, TN, USA
- Prof. Iwao Ojima, Ph.D. – Institute of Chemical Biology & Drug Discovery, State University of New York at Stony Brook, Stony Brook, NY, USA
- Prof. Elizabeth M. Gillam, Ph.D. – School of Biomedical Sciences, The University of Queensland, Brisbane, Australia
- Yune-Fang Ueng, Ph.D. – National Research Institute of Chinese Medicine, Taipei, Taiwan
- Prof. Vessela N. Kristensen, Ph.D. – Institute for Clinical Epidemiology and Molecular Biology (EpiGen), Faculty of Medicine, University of Oslo and Group of Cancer Genome Variation Department of Genetics, Institute for Cancer Research, Rikshospitalet-Radiumhospitalet, Oslo, Norway
- David Hughes, Ph.D. – Department of Physiology & Medical Physics & Centre for Systems Medicine, Royal College of Surgeons Ireland, Dublin, Ireland
- Federico Canzian, Ph.D. – German Cancer Research Center (DKFZ), Heidelberg, Germany
- Prof. Daniele Campa, Ph.D. – Department of Biology, University of Pisa, Pisa, Italy